Real-world comparison of prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or enzalutamide (ENZ). This ...
Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...
• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low ...
Late, persistent, substantial, treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancer. A phase II trial of hypofractionated radiation therapy over five ...
Recent advances in prostate cancer radiotherapy have prioritized techniques that minimize treatment-related toxicity and ...
Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a medical ...
Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...
• Highlights include new safety and efficacy data of Barrigel ™ rectal spacer, the first and only sculptable rectal spacer 1-3 • Teleflex to host Barrigel™ Educational Symposium featuring a physician ...
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results